Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	129,934 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	205,933 L.L
B05BB01	RINGER'S INJECTION USP	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	224,565 L.L
B05BB01	RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	204,554 L.L
B05BB01	RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l		Injectable solution	154,450 L.L
B05BB01	R-SOL	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%		Injectable solution	205,933 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 5mg	5mg	Tablet, chewable	1,034,119 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 5mg	5mg	Tablet, mouth dissolving	518,723 L.L
D03AX	RENEBO	G	β-sitosterol - 0.25% w/w	0.25% w/w	Ointment	456,906 L.L
N02BE51	RHINOSTOP	G	Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg		Tablet, film coated	534,977 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 3mg	3mg	Capsule	842,589 L.L
M03BB53	RELAXON	G	Paracetamol - 300mg, Chlorzoxazone - 250mg		Capsule	296,989 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 3mg	3mg	Capsule	842,589 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	844,701 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 1.5mg	1.5mg	Capsule	684,016 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	228,453 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 1.5mg	1.5mg	Capsule	684,016 L.L
N02BE51	REMIDOL	G	Paracetamol - 650mg, Dextromethorphan HBr - 20mg, Chlorphenamine maleate - 4mg		Granules for solution	537,537 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 200mg	200mg	Tablet, extended release	2,116,552 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 4.5mg	4.5mg	Capsule	842,589 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 300mg	300mg	Tablet, extended release	2,535,831 L.L
N06DA03	RIVASTIGMINE ARROW	G	Rivastigmine - 4.5mg	4.5mg	Capsule	842,589 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,034,119 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, mouth dissolving	405,840 L.L
N05AH04	REZAL XR	G	Quetiapine fumarate - 50mg	50mg	Tablet, extended release	533,505 L.L
D05AX52	ROLIP	G	Calcipotriol - 50mcg, Betamethasone - 0.5mg		Ointment	1,574,983 L.L
N05AX08	RESPAL 1	G	Risperidone - 1mg	1mg	Caplet, film coated	309,084 L.L
N05AX08	RISPERIDONE BIOGARAN	G	Risperidone - 1mg	1mg	Tablet, coated, scored	643,701 L.L
N05AX08	RESPAL 2	G	Risperidone - 2mg	2mg	Caplet, film coated	342,680 L.L
N05AX08	RISPERIDONE BIOGARAN	G	Risperidone - 2mg	2mg	Tablet, coated, scored	1,488,977 L.L

...